Literature DB >> 20100987

Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy.

Barry J Maron1.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20100987     DOI： 10.1161/CIRCULATIONAHA.109.878579

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  65 in total

1.  MRI classification of asymmetric septal hypertrophic cardiomyopathy and its relation to the presence of risk factors.

Authors:  Yasuo Amano; Mitsunobu Kitamura; Morimasa Takayama; Masaki Tachi; Shinichiro Kumita
Journal:  Int J Cardiovasc Imaging       Date:  2012-03-04       Impact factor: 2.357

2.  Clinical spectrum in a family with tropomyosin-mediated hypertrophic cardiomyopathy and sudden death in childhood.

Authors:  Majd Makhoul; Michael J Ackerman; Dianne L Atkins; Ian H Law
Journal:  Pediatr Cardiol       Date:  2010-11-19       Impact factor: 1.655

3.  [The ICD as primary prevention. Rare indications].

Authors:  K Wasmer; J Köbe; C Pott; L Eckardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2010-06

4.  The Electrocardiogram in Athletes Revisited.

Authors:  George D Katritsis; Demosthenes G Katritsis
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-11-29

5.  ESC sudden-death risk model in hypertrophic cardiomyopathy: Incremental value of quantitative contrast-enhanced CMR in intermediate-risk patients.

Authors:  Rocio Hinojar; José Luis Zamorano; Ariana Gonzalez Gómez; Maria Plaza Martin; Amparo Esteban; Luis Miguel Rincón; Juan Carlos Portugal; José Julio Jimenez Nácher; Covadonga Fernández-Golfín
Journal:  Clin Cardiol       Date:  2017-06-14       Impact factor: 2.882

6.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

7.  Left Ventricular Hypertrophy in Rhesus Macaques (Macaca mulatta) at the California National Primate Research Center (1992-2014).

Authors:  J Rachel Reader; Don R Canfield; Jennifer F Lane; Sreetharan Kanthaswamy; Amir Ardeshir; A Mark Allen; Ross P Tarara
Journal:  Comp Med       Date:  2016-04       Impact factor: 0.982

8.  33-year-old man with syncope.

Authors:  Seth H Sheldon; Nicholas M Orme; Kyle W Klarich
Journal:  Mayo Clin Proc       Date:  2011-07       Impact factor: 7.616

9.  Can QT/RR relationship differentiate between low- and high-risk patients with hypertrophic cardiomyopathy?

Authors:  Ricardo A Quinteiro; Marcelo O Biagetti; Adrian Fernandez; Francisco R Borzone; Agustina Gargano; Horacio J Casabe
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-02-01       Impact factor: 1.468

10.  Hypertrophic cardiomyopathy in the Saudi Arabian population: Clinical and echocardiographic characteristics and outcome analysis.

Authors:  Waqas Ahmed; Naveed Akhtar; Odd Bech-Hanssen; Bader Al Mahdi; Talal Al Otaibi; Bahaa M Fadel
Journal:  J Saudi Heart Assoc       Date:  2013-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.